Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

European Journal of Pharmacology

Volumn 166, Issue 3, 1989, Pages 359-366

  Masayuki Hiramatsu, ^a   Cho, Arthur K ^a   Toshitaka, Nabeshima ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

(Rat); 5 HT uptake; Ataxia; Dopamine turnover; MK 801; Phencyclidine (PCP); Stereotyped behavior

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; RADIOISOTOPE;

ANIMAL EXPERIMENT; ATAXIA; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; STEREOTYPY;

ANIMAL; ANTICONVULSANTS; ATAXIA; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; COMPARATIVE STUDY; DIBENZOCYCLOHEPTENES; DIZOCILPINE MALEATE; MALE; MOTOR ACTIVITY; PHENCYCLIDINE; RATS; RATS, INBRED STRAINS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTRANSMITTER; SEROTONIN; STEREOTYPED BEHAVIOR; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0024344248     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(89)90346-4     Document Type: Article

References (40)

1. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate
2. A comparison of PCP-like compounds for NMDA antagonism in two in vivo models
3. An excitant amino acid projection from the medial prefrontal cortex to the anterior part of the nucleus accumbens in the rat
4. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-di-benzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant central sympathomimetic, and apparent anxiolytic properties
5. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands
6. 3H]GABA release from cultured cortex neurons
7. Phencyclidine and related drugs bind to the activated N-methyl-D-aspartate receptor-channel complex in rat brain membranes
8. 3H]DOPA in various regions of the brain
9. Quantitative studies on some antagonists of N-methyl-D-aspartate in slices of rat cerebral cortex
10. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
11. Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats
12. Ethylketocyclazocine (EKC) antagonizes phencyclidine (PCP)-induced stereotyped behaviors by reducing monoamine release
13. Psychopharmacological profile of the N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801
14. The relationship between phencyclidine-induced stereotyped behavior and dopamine release using in vivo voltammetry
15. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats
16. Correlations between phencyclidine-like activity and N-methyl-D-aspartate antagonism: behavioral evidence
17. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys
18. Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists
19. 3H]dopamine in the striatum of the conscious rat
20. Development of tolerance and supersensitivity of phencyclidine in rats after repeated administration of phencyclidine
21. Effects of acute and chronic administration of phencyclidine on the levels of dopamine and metabolites in discrete brain areas of mouse
22. Phencyclidine-induced stereotyped behaviora after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats
23. Effect of lesions in the striatum nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats
24. Serotonergic involvement in phencyclidine-induced behaviors
25. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum
26. Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal contex of rats
27. Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine
28. Antagonism of AP-5- and amphetamine-induced behaviour by time-lotem as compared with clozapine and haloperidol
29. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/σ-receptor
30. 3H]serotonin uptake in synaptosomal preparations from rat brain
31. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release
32. Behavioral rating scales for assessing phencyclidine-induced locomotor activity stereotyped behavior and ataxia in rats
33. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine
34. Pharmaco-kinetic study of apomorphine-induced stereotypy in food deprived rats
35. Phencyclidine-like discriminative stimulus properties of MK-801 in rats
36. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist
37. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes
38. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors
39. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior